Recently CD8+ T cells have been detected in the peripheral blood, cerebrospinal fluid and lesions of MS sufferers and were shown to destroy multiple central nervous system cell substrates, including myelin peptides [65, 66]. The gene discussed is CD8A; the disease is myeloid sarcoma.